Daily creatine slow melanoma tumor growth
Static snapshot — vote, comment, and submit papers on the live app.
Open in Live App →- Not Tested in Humans
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Published 2026Reviewer Insight6/7/2026This study found that giving mice daily creatine injections significantly slowed the growth of melanoma tumors by boosting the activity of dendritic cells — immune cells that direct the body's cancer-fighting response. The researchers also showed that creatine works similarly in human immune cells in laboratory experiments, though no patients were tested.
- Study was done entirely in mice, so results cannot yet be applied to humans
- Only male mice and a single tumor type (B16-OVA melanoma engineered with a model antigen) were used, which may not reflect typical human melanoma
- Creatine was injected into the abdomen of mice — not taken as an oral supplement as humans would use it
- Some evidence suggests creatine could also help tumor cells grow, a risk not fully evaluated here
- The immune mechanism is well-characterized, but the tumor-slowing result rests on one small experiment (6 mice per group, done once)
- Creatine slowed tumor growth but did not stop tumors from eventually progressing
Snapshot built: 2026-06-19